Pharmacogenetic Influence of GST Polymorphisms on Anthracycline-Based Chemotherapy Responses and Toxicity in Breast Cancer Patients: A Multi-Analytical Approach

Glutathione S-transferase M1 and T1 polymorphism and response to neoadjuvant chemotherapy (CAF) in breast cancer patients

(2011) Anjali Mishra et al.   SURGERY TODAY

Glutathione-S-Transferase-Pi Expression in Early Breast Cancer: Association With Outcome and Response to Chemotherapy

(2010) Banu K. Arun et al.   CANCER INVESTIGATION

Gene Polymorphisms in Cyclophosphamide Metabolism Pathway,Treatment-Related Toxicity, and Disease-Free Survival in SWOG 8897 Clinical Trial for Breast Cancer

(2010) S. Yao et al.   CLINICAL CANCER RESEARCH

Germline Mutations and Polymorphisms in the Origins of Cancers in Women

(2010) Kim M. Hirshfield et al.   Journal of Oncology

Correlation of polymorphism C3435T of the MDR-1 gene and the response of primary chemotherapy in women with locally advanced breast cancer

(2009) F.F.O. Rodrigues et al.   GENETICS AND MOLECULAR RESEARCH

Association of Molecular Markers With Toxicity Outcomes in a Randomized Trial of Chemotherapy for Advanced Colorectal Cancer: The FOCUS Trial

(2009) Michael S. Braun et al.   JOURNAL OF CLINICAL ONCOLOGY